Using northern blot analysis, Campbell et al (1998) demonstrated aberrant WT1 expression in four out of five RCC samples and in several RCC-derived cell lines arguing against WT1 being a tumour suppressor in this tumour type. This evidence concerns the gene WT1 and renal cell carcinoma.